L2Be Pharma
ActiveFrom the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
L2Be Pharma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €57,221 and a net result of €14,987. Equity remains stable across the filed financial years (±1.2% per year). Its solvency ranks better than 39% of 4,331 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Directors
1 director
BOUDAKA LEILA
Current
Mandate history
1 person, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| BOUDAKA LEILA |
|